Exposure to diesel exhaust up-regulates iNOS expression in ApoE knockout mice

Toxicol Appl Pharmacol. 2011 Sep 1;255(2):184-92. doi: 10.1016/j.taap.2011.06.013. Epub 2011 Jun 23.

Abstract

Traffic related particulate matter air pollution is a risk factor for cardiovascular events; however, the biological mechanisms are unclear. We hypothesize that diesel exhaust (DE) inhalation induces up-regulation of inducible nitric oxide synthase (iNOS), which is known to contribute to vascular dysfunction, progression of atherosclerosis and ultimately cardiovascular morbidity and mortality.

Methods: ApoE knockout mice (30-week) were exposed to DE (at 200 μg/m³ of particulate matter) or filtered-air (control) for 7 weeks (6 h/day, 5 days/week). iNOS expression in the blood vessels and heart was evaluated by immunohistochemistry and western blotting analysis. To examine iNOS activity, thoracic aortae were mounted in a wire myograph, and vasoconstriction stimulated by phenylephrine (PE) was measured with and without the presence of the specific inhibitor for iNOS (1400 W). NF-κB (p65) activity was examined by ELISA. The mRNA expression of iNOS and NF-κB (p65) was determined by real-time PCR.

Results: DE exposure significantly enhanced iNOS expression in the thoracic aorta (4-fold) and heart (1.5 fold). DE exposure significantly attenuated PE-stimulated vasoconstriction by ~20%, which was partly reversed by 1400 W. The mRNA expression of iNOS and NF-κB was significantly augmented after DE exposure. NF-κB activity was enhanced 2-fold after DE inhalation, and the augmented NF-κB activity was positively correlated with iNOS expression (R²=0.5998).

Conclusions: We show that exposure to DE increases iNOS expression and activity possibly via NF-κB-mediated pathway. We suspect that DE exposure-caused up-regulation of iNOS contributes to vascular dysfunction and atherogenesis, which could ultimately lead to urban air pollution-associated cardiovascular morbidity and mortality.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amidines / pharmacology
  • Animals
  • Aorta, Thoracic / enzymology
  • Aorta, Thoracic / metabolism
  • Apolipoproteins E / deficiency*
  • Apolipoproteins E / genetics
  • Apolipoproteins E / metabolism
  • Atherosclerosis / chemically induced*
  • Atherosclerosis / enzymology
  • Atherosclerosis / metabolism
  • Benzylamines / pharmacology
  • CD36 Antigens / metabolism
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation, Enzymologic / drug effects
  • Male
  • Mice
  • Mice, Knockout
  • Myocardium / enzymology
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Nitric Oxide Synthase Type II / antagonists & inhibitors
  • Nitric Oxide Synthase Type II / biosynthesis*
  • Nitric Oxide Synthase Type II / genetics
  • Particulate Matter / toxicity*
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Tyrosine / analogs & derivatives
  • Tyrosine / metabolism
  • Up-Regulation / drug effects
  • Vasoconstriction / physiology
  • Vehicle Emissions / toxicity*

Substances

  • Amidines
  • Apolipoproteins E
  • Benzylamines
  • CD36 Antigens
  • Enzyme Inhibitors
  • N-(3-(aminomethyl)benzyl)acetamidine
  • NF-kappa B
  • Particulate Matter
  • RNA, Messenger
  • Vehicle Emissions
  • 3-nitrotyrosine
  • Tyrosine
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse